ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December 10, 2004

C. Gordon Zubrod, 84, Dies, Led Chemotherapy Research, Built Cooperative Group System

January 29, 1999

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003